Medtech Industry Urges CMS Chief Oz to Ensure Diabetes Device Access During Awareness Month
In November, during Diabetes Awareness Month, our website will showcase the latest diabetes medtech on its social media channels, website, and LinkedIn. Meanwhile, CMS Administrator Mehmet Oz, a former US Senate candidate, faces pressure from lawmakers and industry leaders over potential access barriers to crucial diabetes management devices in the United States.
Dr. Mehmet Oz, once a Republican candidate for the US Senate in Pennsylvania, now heads the Centers for Medicare and Medicaid Services (CMS). In April 2025, he faced a joint letter from US Senators Susan Collins and Jeanne Shaheen, along with Representatives Diana DeGette and Gus Bilirakis. They urged him not to finalize a proposal that could hinder patient access to continuous glucose monitors (CGMs) and durable insulin pumps in the USA.
Our website, representing the medtech industry, welcomed this bipartisan support. President and CEO Scott Whitaker thanked the legislators for acknowledging the vital role of medtech in managing diabetes for millions of Americans. The website also urged CMS to rectify 'serious flaws' in its proposed durable medical equipment competitive bidding rule, warning of risks to patient safety, fewer product choices, and increased costs for Medicare beneficiaries.
As Diabetes Awareness Month approaches, our website will highlight the latest medtech advancements in diabetes management. Simultaneously, industry leaders and lawmakers call on CMS Administrator Mehmet Oz to ensure full access to proven, safe, and effective diabetes treatment products for Medicare and Medicaid recipients.
